Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1984 Dec;200(6):764–768. doi: 10.1097/00000658-198412000-00016

A prospective randomized study of regional extremity perfusion in patients with malignant melanoma.

F Ghussen, K Nagel, W Groth, J M Müller, H Stützer
PMCID: PMC1250596  PMID: 6508407

Abstract

One hundred seven patients presenting with malignant melanoma of the extremities were included in a prospective randomized study, which was conducted to evaluate the effectiveness of adjuvant hyperthermic regional cytostatic perfusion. In a control group (A, N = 54) the tumors were excised widely and the regional lymph nodes were dissected. The patients in the second group (B, N = 53) received additional hyperthermic (42 C) perfusion with melphalan. The mean follow-up observation period was 554 days. We chose the disease-free survival time as the criterion for success. The study could be discontinued prematurely, since the intermediate evaluation revealed a highly significant difference between the groups (p = 0.0001). We observed 21 local recurrences in the control group and four recurrences in the perfusion group. The retrospective breakdown by clinical stages also showed significant differences. The recurrence rate in the control group was 27.8% in Stage I, 31.6% in Stage II, and 58.8% in Stage III. In the perfusion group we observed recurrences equaling 5.6% in Stage I, 5.5% in Stage II, and 12.5% in Stage III. The differences between the groups based on the target-criterion of disease-free survival represent significance levels of p = 0.09 in Stage I, p = 0.03 in Stage II, and p = 0.003 in Stage III. We feel that on the evidence provided by our study, shown in the above results, the adjuvant application of regional hyperthermic cytostatic perfusion has proven itself to be superior to conventional procedures alone.

Full text

PDF
765

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amer M. H., Al-Sarraf M., Vaitkevicius V. K. Clinical presentation, natural history and prognostic factors in advanced malignant melanoma. Surg Gynecol Obstet. 1979 Nov;149(5):687–692. [PubMed] [Google Scholar]
  2. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970 Nov;172(5):902–908. doi: 10.1097/00000658-197011000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CREECH O., Jr, KREMENTZ E. T., RYAN R. F., WINBLAD J. N. Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg. 1958 Oct;148(4):616–632. doi: 10.1097/00000658-195810000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cavaliere R., Ciocatto E. C., Giovanella B. C., Heidelberger C., Johnson R. O., Margottini M., Mondovi B., Moricca G., Rossi-Fanelli A. Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer. 1967 Sep;20(9):1351–1381. doi: 10.1002/1097-0142(196709)20:9<1351::aid-cncr2820200902>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  5. Clark W. H., Jr, From L., Bernardino E. A., Mihm M. C. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969 Mar;29(3):705–727. [PubMed] [Google Scholar]
  6. Dickson J. A., Suzangar M. A predictive in vitro assay for the sensitivity of human solid tumours to hyperthermia (42 degrees C) and its value in patient management. Clin Oncol. 1976 Jun;2(2):141–155. [PubMed] [Google Scholar]
  7. Fajardo L. F., Egbert B., Marmor J., Hahn G. M. Effects of hyperthermia in a malignant tumor. Cancer. 1980 Feb;45(3):613–623. doi: 10.1002/1097-0142(19800201)45:3<613::aid-cncr2820450331>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  8. Fortner J. G., Woodruff J., Schottenfeld D., Maclean B. Biostatistical basis of elective node dissection for malignant melanoma. Ann Surg. 1977 Jul;186(1):101–103. doi: 10.1097/00000658-197707000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ghussen F., Isselhard W. The limit of hyperthermic strain on skeletal muscle tissue during regional perfusion. Res Exp Med (Berl) 1984;184(2):115–123. doi: 10.1007/BF01852358. [DOI] [PubMed] [Google Scholar]
  10. Ghussen F., Nagel K., Sturz I., Isselhard W. Eine modifizierte Farbstoffverdünnungsmethode zur Uberprüfung der Kreislaufisolierung der Extremität während regionaler perfusion. Res Exp Med (Berl) 1982;180(2):179–187. doi: 10.1007/BF01851057. [DOI] [PubMed] [Google Scholar]
  11. Goldsmith H. S., Shah J. P., Kim D. H. Prognostic significance of lymph node dissection in the treatment of malignant melanoma. Cancer. 1970 Sep;26(3):606–609. doi: 10.1002/1097-0142(197009)26:3<606::aid-cncr2820260317>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  12. Hill G. J., 2nd, Moss S. E., Golomb F. M., Grage T. B., Fletcher W. S., Minton J. P., Krementz E. T. DTIC and combination therapy for melanoma: III. DTIC (NSC 45388) Surgical Adjuvant Study COG PROTOCOL 7040. Cancer. 1981 Jun 1;47(11):2556–2562. doi: 10.1002/1097-0142(19810601)47:11<2556::aid-cncr2820471107>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  13. Janoff K. A., Moseson D., Nohlgren J., Davenport C., Richards C., Fletcher W. S. The treatment of state I melanoma of the extremities with regional hyperthermic isolation perfusion. Ann Surg. 1982 Sep;196(3):316–323. doi: 10.1097/00000658-198209000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. KLOPP C. T., ALFORD T. C., BATEMAN J., BERRY G. N., WINSHIP T. Fractionated intra-arterial cancer; chemotherapy with methyl bis amine hydrochloride; a preliminary report. Ann Surg. 1950 Oct;132(4):811–832. doi: 10.1097/00000658-195010000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Karakousis C. P., Temple D. F., Moore R., Ambrus J. L. Prognostic parameters in recurrent malignant melanoma. Cancer. 1983 Aug 1;52(3):575–579. doi: 10.1002/1097-0142(19830801)52:3<575::aid-cncr2820520333>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  16. Krementz E. T., Carter R. D., Sutherland C. M., Campbell M. The use of regional chemotherapy in the management of malignant melanoma. World J Surg. 1979 Jul 30;3(3):289–304. doi: 10.1007/BF01556579. [DOI] [PubMed] [Google Scholar]
  17. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  18. Mantel N. Ranking procedures for arbitrarily restricted observation. Biometrics. 1967 Mar;23(1):65–78. [PubMed] [Google Scholar]
  19. Pocock S. J. Interim analyses for randomized clinical trials: the group sequential approach. Biometrics. 1982 Mar;38(1):153–162. [PubMed] [Google Scholar]
  20. Schraffordt Koops H., Beekhuis H., Oldhoff J., Oosterhuis J. W., van der Ploeg E., Vermey A. Local recurrence and survival in patients with (Clark Level IV/V and over 1.5-mm thickness) stage I malignant melanoma of the extremities after regional perfusion. Cancer. 1981 Nov 1;48(9):1952–1957. doi: 10.1002/1097-0142(19811101)48:9<1952::aid-cncr2820480907>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  21. Stehlin J. S., Jr, Giovanella B. C., de Ipolyi P. D., Anderson R. F. Eleven years' experience with hyperthermic perfusion for melanoma of the extremities. World J Surg. 1979 Jul 30;3(3):305–307. doi: 10.1007/BF01556581. [DOI] [PubMed] [Google Scholar]
  22. Stehlin J. S., Jr Hyperthermic perfusion with chemotherapy for cancers of the extremities. Surg Gynecol Obstet. 1969 Aug;129(2):305–308. [PubMed] [Google Scholar]
  23. Sugarbaker E. V., McBride C. M. Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremities. Cancer. 1976 Jan;37(1):188–198. doi: 10.1002/1097-0142(197601)37:1<188::aid-cncr2820370127>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  24. Veronesi U., Adamus J., Aubert C., Bajetta E., Beretta G., Bonadonna G., Bufalino R., Cascinelli N., Cocconi G., Durand J. A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. N Engl J Med. 1982 Oct 7;307(15):913–916. doi: 10.1056/NEJM198210073071503. [DOI] [PubMed] [Google Scholar]
  25. Veronesi U., Adamus J., Bandiera D. C., Brennhovd I. O., Caceres E., Cascinelli N., Claudio F., Ikonopisov R. L., Javorskj V. V., Kirov S. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med. 1977 Sep 22;297(12):627–630. doi: 10.1056/NEJM197709222971202. [DOI] [PubMed] [Google Scholar]
  26. Wood W. C., Cosimi A. B., Carey R. W., Kaufman S. D. Randomized trial of adjuvant therapy for "high risk" primary malignant melanoma. Surgery. 1978 Jun;83(6):677–681. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES